EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

The Management of Congenital Cytomegalovirus Infection in an Era of Universal Newborn CMV Screening

Emily R Harrison, W Charles Huskins iD, Mark R Schleiss iD

Reviews in Medical Virology · 2026

DOI: 10.1002/rmv.70132 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Reviews in Medical Virology, 2026. Verfasst von Emily R Harrison und 2 weiteren Autor:innen. Beteiligte Einrichtung: Division of Infectious Diseases, Children's Minnesota, St. Paul, Minnesota, USA. Hauptthemen laut MEDLINE: Cytomegalovirus Infections, Neonatal Screening. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 144 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NICHD NIH HHS, NIH HHS, National Institutes of Health.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The most common infectious disease responsible for paediatric developmental disability is congenital infection with human cytomegalovirus (cCMV). Many serious sequelae are caused by cCMV, including microcephaly, intracranial calcifications, neuronal migration defects, seizure disorders, developmental delay, and sensorineural hearing loss (SNHL). Although long‐term neurodevelopmental impairment is clearly more common in newborns with clinically apparent disease at birth, more knowledge is needed about management in the era of universal cCMV screening, since screening identifies infants that, in the past, would not have been discovered during routine newborn care—infants that we reference in this review as having clinically inapparent cCMV (CICMV) infections. For newborns identified with CICMV infections by universal cCMV screening, longitudinal audiologic assessment is needed, but other necessary laboratory and neuroimaging studies, as well as indications for antiviral therapy, are uncertain. This review summarises current concepts about the approach to cCMV infections identified by universal screening, with emphasis on the CICMV infant. We identify areas for future research that should inform and direct future evaluation and management of these infants.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Cytomegalovirus InfectionsNeonatal ScreeningHumansInfant, NewbornAntiviral AgentsCytomegalovirusHearing Loss, SensorineuralDisease Management

Stichwörter der Autor:innen

CMVantiviralhuman cytomegalovirusnewborn screeningsensorineural hearing loss

Substanzen

Antiviral Agents

Autor:innen und Institutionen

  • Division of Infectious Diseases, Children's Minnesota, St. Paul, Minnesota, USA.
  • Division of Pediatric Infectious Diseases, Mayo Clinic College of Medicine and Science, Rochester, Minnesota, USA.
  • Division of Pediatric Infectious Diseases, University of Minnesota Medical School, Minneapolis, Minnesota, USA.

ORCID-Profile: W Charles Huskins, Mark R Schleiss

Förderung

  • NICHD NIH HHS
  • NIH HHS
  • National Institutes of Health

Zitieren

APA

Harrison, E. R., Huskins, W. C., & Schleiss, M. R. (2026). The Management of Congenital Cytomegalovirus Infection in an Era of Universal Newborn CMV Screening. Reviews in Medical Virology. https://doi.org/10.1002/rmv.70132

Vancouver

Harrison ER, Huskins WC, Schleiss MR. The Management of Congenital Cytomegalovirus Infection in an Era of Universal Newborn CMV Screening. Reviews in Medical Virology. 2026. doi:10.1002/rmv.70132

BibTeX
@article{Harrison2026,
  author = {Harrison, Emily R and Huskins, W Charles and Schleiss, Mark R},
  title = {The Management of Congenital Cytomegalovirus Infection in an Era of Universal Newborn CMV Screening},
  journal = {Reviews in Medical Virology},
  year = {2026},
  doi = {10.1002/rmv.70132}
}
Kostenlos starten →